Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.580
-0.130 (-7.60%)
At close: Feb 17, 2026, 4:00 PM EST
1.580
0.00 (0.02%)
After-hours: Feb 17, 2026, 5:57 PM EST

PACB Statistics

Total Valuation

PACB has a market cap or net worth of $477.01 million. The enterprise value is $908.99 million.

Market Cap477.01M
Enterprise Value 908.99M

Important Dates

The last earnings date was Thursday, February 12, 2026, after market close.

Earnings Date Feb 12, 2026
Ex-Dividend Date n/a

Share Statistics

PACB has 301.91 million shares outstanding. The number of shares has increased by 9.28% in one year.

Current Share Class 301.91M
Shares Outstanding 301.91M
Shares Change (YoY) +9.28%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) 0.74%
Owned by Institutions (%) 63.57%
Float 296.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.21
Forward PS 2.77
PB Ratio 96.52
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.68
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.92, with a Debt / Equity ratio of 131.32.

Current Ratio 6.92
Quick Ratio 5.79
Debt / Equity 131.32
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -80.18

Financial Efficiency

Return on equity (ROE) is -213.45% and return on invested capital (ROIC) is -36.94%.

Return on Equity (ROE) -213.45%
Return on Assets (ROA) -34.09%
Return on Invested Capital (ROIC) -36.94%
Return on Capital Employed (ROCE) -76.41%
Weighted Average Cost of Capital (WACC) 7.33%
Revenue Per Employee $278,270
Profits Per Employee -$950,219
Employee Count575
Asset Turnover 0.16
Inventory Turnover 1.95

Taxes

In the past 12 months, PACB has paid $318,000 in taxes.

Income Tax 318,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.59% in the last 52 weeks. The beta is 2.28, so PACB's price volatility has been higher than the market average.

Beta (5Y) 2.28
52-Week Price Change -14.59%
50-Day Moving Average 2.08
200-Day Moving Average 1.61
Relative Strength Index (RSI) 32.20
Average Volume (20 Days) 8,233,609

Short Selling Information

The latest short interest is 35.59 million, so 11.79% of the outstanding shares have been sold short.

Short Interest 35.59M
Short Previous Month 35.09M
Short % of Shares Out 11.79%
Short % of Float 12.02%
Short Ratio (days to cover) 4.21

Income Statement

In the last 12 months, PACB had revenue of $160.01 million and -$546.38 million in losses. Loss per share was -$1.82.

Revenue160.01M
Gross Profit 54.85M
Operating Income -557.56M
Pretax Income -546.06M
Net Income -546.38M
EBITDA -52.65M
EBIT -557.56M
Loss Per Share -$1.82
Full Income Statement

Balance Sheet

The company has $279.51 million in cash and $702.42 million in debt, with a net cash position of -$422.92 million or -$1.40 per share.

Cash & Cash Equivalents 279.51M
Total Debt 702.42M
Net Cash -422.92M
Net Cash Per Share -$1.40
Equity (Book Value) 5.35M
Book Value Per Share 0.02
Working Capital 322.17M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 34.28%
Operating Margin -348.46%
Pretax Margin -341.28%
Profit Margin n/a
EBITDA Margin -32.91%
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PACB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.28%
Shareholder Yield -9.28%
Earnings Yield -112.41%
FCF Yield n/a

Analyst Forecast

The average price target for PACB is $2.08, which is 31.65% higher than the current price. The consensus rating is "Buy".

Price Target $2.08
Price Target Difference 31.65%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 11.41%
EPS Growth Forecast (5Y) -20.71%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3